Eureka Therapeutics hauls in $60 mln Series D
Emeryville, California-based Eureka Therapeutics Inc, a clinical stage biotechnology focused on treating solid tumors, has closed $60 million in Series D financing. Acorn Pacific Ventures led the round with participation from other investors that included GP Capital.
23 January 2018•1 min read
